NMR Metabolomics of Primary Ovarian Cancer Cells in Comparison to Established Cisplatin-Resistant and -Sensitive Cell Lines
Article in Cells (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathway
Article in Gynecologic Oncology (April 2023)
Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1
Article in Scientific Reports (January 2023)